View Larger Image Gaceta Médica, leading newspaper in health information, interviews Dra. Isabel Portero, CEO & Founder of BIOHOPE “Closer to the personalization of renal transplant treatment. First study to evaluate the functionality of the immunobiogram to predict the immunosuppressive response.” > Read More Carolina Martin2018-07-27T11:17:11+00:00July 26th, 2018|Clinical Development, Research|0 Comments Share This Story, Choose Your Platform! TwitterLinkedInWhatsapp Related Posts Different media publish the new of the success of the immunobiogram July 15th, 2018 | 0 Comments BIOHOPE received the approval from the Ethics Committees for the TRANSBIO clinical study that will be developed in collaboration with 8 international hospitals May 11th, 2018 | 0 Comments INMUNOBIOGRAM, Biohope’s test, facilitates the personalization of immunosuppressive treatment in patients with kidney transplantation October 3rd, 2017 | 0 Comments BIOHOPE WILL EXPLAIN THE PROMISING DATA FROM PILOT STUDY TO THEIR SCIENTIFIC ADVISORY BOARD September 12th, 2017 Biohope has initiated the first Clinical Trial in hospitals February 10th, 2017
